Medicare Enrolled

Dr. Bhanu Sud, MD

Infectious Disease · Placentia, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1275 N ROSE DR, Placentia, CA 92870
7149966500
In practice since 2007 (19 years)
NPI: 1972643344 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sud? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sud

Dr. Bhanu Sud is an infectious disease specialist in Placentia, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sud performed 2,601 Medicare services across 769 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sud received a total of $43,126 from 28 pharmaceutical and/or device companies across 363 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in CA $43,126 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,601
Medicare services
Top 14% in CA for infectious disease
769
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~137 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
2,021 $66 $100
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
327 $145 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
202 $94 $150
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
20 $91 $120
New patient office visit, complex (60-74 min) 16 $163 $275
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
15 $100 $130
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$43,126
Total received (2018-2024)
Avg $6,161/year across 7 years
Top 7% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
363
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,887 (90.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,240 (9.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,298
2023
$5,342
2022
$3,141
2021
$1,853
2020
$6,881
2019
$9,045
2018
$10,568

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,260
Merck Sharp & Dohme LLC
$277
ViiV Healthcare Company
$253
Gilead Sciences, Inc.
$154
Astellas Pharma US Inc
$100
Shionogi Inc
$86
Melinta Therapeutics, LLC
$70
Takeda Pharmaceuticals U.S.A., Inc.
$34
Theratechnologies Inc.
$22
Paratek Pharmaceuticals, Inc.
$22
Insmed, Inc.
$19
Top 3 companies account for 91.9% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$16,978
Allergan, Inc.
$7,714
ABBVIE INC.
$7,534
AbbVie Inc.
$6,011
ViiV Healthcare Company
$1,061
Gilead Sciences, Inc.
$689
Merck Sharp & Dohme LLC
$547
Merck Sharp & Dohme Corporation
$386
Janssen Biotech, Inc.
$356
Accelerate Diagnostics Inc.
$252
Insmed, Inc.
$236
Melinta Therapeutics, LLC
$224
Shionogi Inc
$208
Melinta Therapeutics, Inc.
$135
Theratechnologies Inc.
$134
Astellas Pharma US Inc
$123
Cumberland Pharmaceuticals, Inc.
$120
Theravance Biopharma, Inc.
$86
Philips Electronics North America Corporation
$84
Janssen Pharmaceuticals, Inc
$61
Takeda Pharmaceuticals U.S.A., Inc.
$34
Ferring Pharmaceuticals Inc.
$27
Dynavax Technologies Corporation
$27
Paratek Pharmaceuticals, Inc.
$22
VYERA PHARMACEUTICALS, LLC
$20
MAYNE PHARMA INC.
$20
Nabriva Therapeutics, plc
$19
Napo Pharmaceuticals Inc
$17
Top 3 companies account for 74.7% of all-time payments
Associated products mentioned in payments ›
ACCELERATE PHENO · APRETUDE · AVYCAZ · Arikayce · Baxdela · CABENUVA · CALDOLOR · CRESEMBA · CUVITRU · DALVANCE · DIFICID · DOVATO · Daraprim · EGRIFTA · EGRIFTA SV · Fetroja · Heplisav-B · ISENTRESS · JULUCA · Kimyrsa · Mytesi · NOXAFIL · NUZYRA · RUKOBIA · Rezzayo · SYMTUZA · TEFLARO · TRIUMEQ · TROGARZO · Trilogy 100 · VIBATIV · Vabomere · Veklury · Vibativ · Xenleta · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for infectious disease in CA.

Looking for an infectious disease specialist in Placentia?
Compare infectious diseases in the Placentia area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
165
Per 100K population
5.2
County median income
$113,702
Nearest hospital
UCI HEALTH - PLACENTIA LINDA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sud is a mixed practice specialist, with above-average Medicare volume (top 14% in CA), with speaking/promotional industry engagement in the top 7% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sud experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Sud performed 2,021 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sud receive payments from pharmaceutical companies?
Yes. Dr. Sud received a total of $43,126 from 28 companies across 363 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sud's costs compare to other infectious diseases in Placentia?
Dr. Sud's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →